arrow
L

Lorenzo Gaetani

section of neurology
H指数:31
被引数:4,530

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Application of unsupervised and supervised machine learning approaches to blood-based biomarkers of Alzheimer’s disease in a memory clinic cohort

无监督和监督机器学习方法在记忆门诊队列中阿尔茨海默病血液生物标志物中的应用

2026-09-270
OA
Cerebrospinal fluid and plasma biomarkers in idiopathic normal pressure hydrocephalus: comparison with Alzheimer's and Parkinson's diseases

脑脊液和血浆生物标志物在特发性正常压力脑积水中的研究:与阿尔茨海默病和帕金森病的比较

2026-08-280
OA
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias

血浆蛋白质组分析确定了神经退行性痴呆的鉴别诊断疾病和分子分期的生物标志物

2026-07-200
OAAI
Transcriptome analysis of the prefrontal cortex identifies inflammatory genes associated with cognitive impairment in a model of multiple sclerosis

前额叶皮层转录组分析识别出与多发性硬化模型中认知障碍相关的炎症基因

2026-03-250
OAAI
Blood-based biomarkers for Alzheimer’s disease diagnosis: a joint position paper from the Italian Societies of Neurology (SIN) and of Clinical Biochemistry and Clinical Molecular Biology - Laboratory Medicine(SIBioC) and from the Autonomous Association affiliated with SIN for dementia (SINdem)

阿尔茨海默病诊断的血液生物标志物:意大利神经病学学会(SIN)和临床化学与临床分子生物学-实验室医学学会(SIBioC)以及与SIN相关的痴呆症自主协会(SINdem)联合立场文件

2026-03-210
OAAI
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders

一种用于路易体病诊断的定量多巴脱羧酶生物标志物

2026-02-012
PRE
Prognostic value of kappa free light chain index in patients with primary progressive multiple sclerosis

κ游离轻链指数在原发性进展型多发性硬化患者中的预后价值

2025-11-070
OAAI
Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer’s disease

意大利跨学会关于重组阿尔茨海默病中抗淀粉样蛋白单克隆抗体实施与合理应用的诊断-治疗路径的建议

2025-10-170
OA
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers

参考蛋白质以改善核心1型和核心2型阿尔茨海默病脑脊液和血浆生物标志物

Brain
IF11.7
2025-10-060
OAAI